miR-150 and miR-194 inhibit the activation of hepatic stellate cells by inhibiting the expression of c-MYB and RAC1, leading to the reduction of collagen deposition in liver fibrosis [43]. The gene discussed is RAC1; the disease is Hepatic fibrosis.